Centuple Global Limited (BOM:531099)
44.34
-2.33 (-4.99%)
At close: Jun 2, 2026
Centuple Global Revenue
In the fiscal year ending March 31, 2026, Centuple Global had annual revenue of 5.74B INR with 114,387.41% growth. Centuple Global had revenue of 2.79B in the quarter ending March 31, 2026, with 111,666.64% growth.
Revenue
5.74B
Revenue Growth
+114,387.41%
P/S Ratio
0.04
Revenue / Employee
1.43B
Employees
4
Market Cap
242.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.74B | 5.73B | 114,387.41% |
| Mar 31, 2025 | 5.01M | -6.30M | -55.68% |
| Mar 31, 2024 | 11.31M | -308.79K | -2.66% |
| Mar 31, 2023 | 11.62M | -8.50M | -42.26% |
| Mar 31, 2022 | 20.12M | 15.27M | 314.82% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dipna Pharmachem | 1.07B |
| Medico Intercontinental | 853.55M |
| Medistep Healthcare | 708.54M |
| Constronics Infra | 503.25M |
| Chandra Bhagat Pharma | 493.95M |
| Zenlabs Ethica | 471.07M |
| Evoq Remedies | 267.57M |
| Muller & Phipps (India) | 69.08M |